Pharmacists in Rocky Mount, Virginia


12 Pharmacists found in Rocky Mount
female pharmacist

Carolyn Anne Kilbane, PHARMD


Pharmacist
290 Old Franklin Tpke, Rocky Mount, VA 24151
540-482-0206    

male pharmacist

Casey Whitaker, PHARMD


Pharmacist
400 Old Franklin Tpke, Rocky Mount, VA 24151
540-483-2667     540-483-1624

female pharmacist

Courtney Herron, PHARM D


Pharmacist
290 Old Franklin Tpke, Rocky Mount, VA 24151
540-482-0206    



male pharmacist

Dr. Danny R Timney, PHARM. D.


Pharmacist
400 Old Franklin Tpke, Rocky Mount, VA 24151
540-483-2667     540-483-1624

female pharmacist

Dr. Ellen Kaltenbach, PHARM. D.


Pharmacist
970 Franklin St, Rocky Mount, VA 24151
540-483-0258     540-484-1039

male pharmacist

Jung Bum Chun, PHARMD


Pharmacist
290 Old Franklin Tpke, Rocky Mount, VA 24151
540-482-0206    

female pharmacist

Kimberly Florio, PHARMD


Pharmacist
970 Franklin St, Rocky Mount, VA 24151
540-483-0258    

female pharmacist

Mrs. Lori Board Mcclure, RPH


Pharmacist
180 Floyd Ave, Rocky Mount, VA 24151
540-489-6366     540-489-6565

female pharmacist

Dr. Mallory Fralin, PHARMD


Pharmacist
485 Old Franklin Tpke, Rocky Mount, VA 24151
540-483-1178     540-483-2933

male pharmacist

Mr. Rick H Orange, RPH


Pharmacist
200 Parkside Ln, Rocky Mount, VA 24151
540-309-9593    

male pharmacist

Mr. Samuel Wallace Cundiff Jr., RPH


Pharmacist
550 Old Franklin Turnpike, Rocky Mount, VA 24151
540-484-1100    

female pharmacist

Sarah Mcmillan


Pharmacist
485 Old Franklin Tpke, Rocky Mount, VA 24151
540-483-1178    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.